Referring patients to MoleMap takes the guesswork out of diagnosing skin cancer.
Our system combines proven skin-mapping technology and skin cancer expertise to spot melanoma early – when it's most treatable.
3 reasons to refer patients to MoleMap
Early detection is key: patients diagnosed with a Breslow thickness of <1 mm have a five-year survival rate of between 97–99%, compared to 32–69% for those >4.0 mm.2
Data from our Virtual Lesion Clinics shows that when patients present with one lesion of concern, there’s often another hiding in plain sight.9
Our surveillance and diagnostic services can give you and your patient piece of mind, because lesions are double-checked and diagnosed by an expert Dermatologist.
We don’t perform skin cancer surgery, so we return the patient to you, decreasing the number of benign lesions needing excision. MoleMap has an NNT (number needed to treat) of 4.8 for melanoma.6
Did you know there's an easy referral built into all MedTech software?
Who should you refer? Any patients with suspicious or atypical moles or lesions, with 50+ moles, or with a family or personal history of melanoma (see what to look for).